Annual Non Current Assets
$15.11 B
+$849.10 M+5.96%
31 December 2023
Summary:
Royalty Pharma annual long term assets is currently $15.11 billion, with the most recent change of +$849.10 million (+5.96%) on 31 December 2023. During the last 3 years, it has risen by +$1.78 billion (+13.39%). RPRX annual non current assets is now at all-time high.RPRX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$16.25 B
+$1.17 B+7.76%
30 September 2024
Summary:
Royalty Pharma quarterly long term assets is currently $16.25 billion, with the most recent change of +$1.17 billion (+7.76%) on 30 September 2024. Over the past year, it has increased by +$2.12 billion (+15.01%). RPRX quarterly non current assets is now at all-time high.RPRX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPRX Non Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +6.0% | +15.0% |
3 y3 years | +13.4% | +8.6% |
5 y5 years | +72.4% | - |
RPRX Non Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +13.4% | at high | +15.0% |
5 y | 5 years | at high | +72.4% | at high | +39.9% |
alltime | all time | at high | +72.4% | at high | +39.9% |
Royalty Pharma Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $16.25 B(+7.8%) |
June 2024 | - | $15.08 B(+3.5%) |
Mar 2024 | - | $14.57 B(-3.6%) |
Dec 2023 | $1.27 B(-50.1%) | $15.11 B(+6.9%) |
Sept 2023 | - | $14.13 B(-0.3%) |
June 2023 | - | $14.17 B(-1.9%) |
Mar 2023 | - | $14.44 B(+1.3%) |
Dec 2022 | $2.55 B | $14.26 B(-7.0%) |
Sept 2022 | - | $15.33 B(+7.7%) |
June 2022 | - | $14.24 B(-1.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $14.40 B(-1.6%) |
Dec 2021 | $2.88 B(+6.7%) | $14.64 B(-2.1%) |
Sept 2021 | - | $14.96 B(+8.3%) |
June 2021 | - | $13.81 B(+2.3%) |
Mar 2021 | - | $13.50 B(+1.3%) |
Dec 2020 | $2.70 B(+224.1%) | $13.32 B(+0.9%) |
Sept 2020 | - | $13.21 B(+7.4%) |
June 2020 | - | $12.29 B(+5.7%) |
Mar 2020 | - | $11.63 B(+0.1%) |
Dec 2019 | $832.07 M(-68.1%) | $11.62 B |
Dec 2018 | $2.61 B | - |
FAQ
- What is Royalty Pharma annual long term assets?
- What is the all time high annual non current assets for Royalty Pharma?
- What is Royalty Pharma annual non current assets year-on-year change?
- What is Royalty Pharma quarterly long term assets?
- What is the all time high quarterly non current assets for Royalty Pharma?
- What is Royalty Pharma quarterly non current assets year-on-year change?
What is Royalty Pharma annual long term assets?
The current annual non current assets of RPRX is $15.11 B
What is the all time high annual non current assets for Royalty Pharma?
Royalty Pharma all-time high annual long term assets is $15.11 B
What is Royalty Pharma annual non current assets year-on-year change?
Over the past year, RPRX annual long term assets has changed by +$849.10 M (+5.96%)
What is Royalty Pharma quarterly long term assets?
The current quarterly non current assets of RPRX is $16.25 B
What is the all time high quarterly non current assets for Royalty Pharma?
Royalty Pharma all-time high quarterly long term assets is $16.25 B
What is Royalty Pharma quarterly non current assets year-on-year change?
Over the past year, RPRX quarterly long term assets has changed by +$2.12 B (+15.01%)